Trial intelligence / Profile preview

Protamine versus placebo for heparin reversal after transfemoral TAVI

ACTRN12621001261808Phase 4Completed

Sponsor
Antony Walton
Start
Dec 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of protamine in aortic stenosis (AS) (2 arms), sponsored by Antony Walton. Primary endpoint: Procedural haemostasis failure and time to haemostasis. Started Dec 2021; status: completed.

02

Drugs

protamine
03

Conditions

aortic stenosis (AS)

Beyond the preview

Go deeper on ACTRN12621001261808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621001261808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call